Form 8-K - Current report:
SEC Accession No. 0001567264-24-000053
Filing Date
2024-11-13
Accepted
2024-11-13 16:10:47
Documents
15
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20241113.htm   iXBRL 8-K 29469
2 EX-99.1 ints20241113ex99120240930p.htm EX-99.1 80851
6 image01.jpg GRAPHIC 4474
  Complete submission text file 0001567264-24-000053.txt   258101

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20241113.xsd EX-101.SCH 1827
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20241113_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20241113_pre.xml EX-101.PRE 13606
17 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20241113_htm.xml XML 2935
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 241454280
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)